HBM Holdings Limited (HKG:2142)
Hong Kong
· Delayed Price · Currency is HKD 8.21
+0.27 (3.40%)
Apr 25, 2025, 4:08 PM HKT
HBM Holdings Revenue
In the year 2024, HBM Holdings had annual revenue of $38.10M USD, down -57.43%. HBM Holdings had revenue of $14.40M in the half year ending December 31, 2024, with 10.52% growth.
Revenue
$38.10M
Revenue Growth
-57.43%
P/S Ratio
21.53
Revenue / Employee
$208.20K
Employees
183
Market Cap
6.37B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |